BioSpace News Archive

On August 26 2020, Claigan Environmental Inc. will present a webinar on common practices to manage the nanomaterials requirements of the EU Medical Device Regulation.

Advanzeon Solutions Inc. (OTC PINK:CHCR) (“Advanzeon”) announced today that its wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. dba SleepMaster Solutions™ (collectively, the “Company”), will start using a revolutionary, disposable home sleep test device known as the WatchPAT™ ONE which utilizes cloud-based technology for the immediate upload of testing data.

Remarkable things are happening as the nation’s medical laboratories and anatomic pathology groups answer the challenges of the COVID-19 pandemic and the need for ever-greater numbers of SARS-CoV-2 tests

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the appointment of Kristen Stewart to the newly created position of senior vice president of Strategy and Investor Relations.

Gilead Sciences, Inc. (Nasdaq: GILD) and Tango Therapeutics today announced an expanded strategic collaboration focused on the discovery, development and commercialization of innovative targeted immune evasion therapies for patients with cancer.

Seres Therapeutics, Inc. (Nasdaq: MCRB) (“Seres”), a leading microbiome therapeutics platform company developing a novel class of multifunctional bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease, today announced the closing of an underwritten public offering of 12,075,000 shares of its common stock, at a public offering price of $21.50 per share

Schrödinger, Inc., whose differentiated, physics-based software platform enables discovery of high-quality, novel molecules for drug development and materials applications, announced the closing of its underwritten public offering of 5,750,000 shares of its common stock at a public offering price of $66.00 per share.

Pinnacle Clinical Research (“Pinnacle”), a medical clinical research organization specializing in Hepatological and Gastroenterological research is providing notice to individuals impacted by the exposure of certain protected information.

LG Chem Life Sciences (“LG Chem”), a division of LG Chem, and TransThera Biosciences Co. Ltd. (“TransThera”), a clinical-stage biotechnology company based in Nanjing, China, announced today that LG Chem has entered an exclusive license agreement with TransThera

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced financial results for the second quarter ended June 30, 2020 and provided a business update.